 NEW YORK--BUSINESS WIRE--CM Life Sciences III Inc. the Company announced today that it closed its initial public offering of 55,200,000 units at 10.00 per unit, including 7,200,000 units issued pursuant to the exercise in full by the underwriters of its over-allotment option. The units are listed on The Nasdaq Capital Market Nasdaq and began trading under the ticker symbol CMLTU on April 7, 2021. Each unit consists of one share of Class A common stock and one-fifth of one redeemabl 